The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 31.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 320.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 859.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 491.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 500.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 67.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 847.
The residues at positions 238 and 242, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The residues at positions 105 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-253).
The residues at positions 227 and 253, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-105).
The residues at positions 11 and 17, specifically V and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Val-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1058.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1083.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 12.
The residues at positions 1 and 34, specifically N and G, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Asn-Gly).
The residues at positions 7 and 28, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as 2-cysteinyl-D-allo-threonine (Cys-Thr).
The residues at positions 13 and 22, specifically C and F, respectively, take part in an intrachain covalent linkage referred to as 2-cysteinyl-L-phenylalanine (Cys-Phe).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 785.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 811.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 842.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1284.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 38.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 183.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 44.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 196.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 209.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 223.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 253.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 263.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 285.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 295.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 317.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 327.
The residues at positions 98 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The residues at positions 1 and 30, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 357.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 436.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 458.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 552.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 641.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 702.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 711.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 723.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 723.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 741.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 801.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 810.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 875.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 949.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 992.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1041.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 194.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 207.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 209.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 278.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 300.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 305.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 306.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 362.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 446.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 455.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 30.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 147.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 438.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 721.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 9.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 802.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2509.
The residues at positions 141 and 143, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 58.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 324.
The residues at positions 96 and 218, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-244).
The residues at positions 218 and 244, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 147.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 763.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-186 in ATG5), involves the residue G present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 42.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 234.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 37.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 180.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 296.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 301.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 336.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 373.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 410.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 438.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 476.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 558.
The residues at positions 101 and 224, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-250).
The residues at positions 224 and 250, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-101).
The residues at positions 183 and 197, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 229.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 244.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 295.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1127.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 321.
The residues at positions 196 and 198, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 220.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 345.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 584.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 606.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 626.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 649.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 658.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 686.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 731.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 9.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 135.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 87.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 98.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 48.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 76.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 130.
The residues at positions 113 and 240, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-266).
The residues at positions 240 and 266, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-113).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 126.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 143.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 333.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 333.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 355.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 454.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 465.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 480.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 480.
The residues at positions 240 and 244, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 141.
The residues at positions 33 and 38, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 35 and 49, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 42 and 50, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 67.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 97.
The residues at positions 148 and 150, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3), involves the residue K present at position 38.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 441.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 485.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 629.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 83.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 19.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 214.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 214.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 332.
The residues at positions 142 and 144, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 179.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 179.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 485.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 17.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 39.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 45.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 46.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 97.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-97 in ATG5), involves the residue G present at position 120.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-452), involves the residue M present at position 334.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-334), involves the residue K present at position 452.
The residues at positions 1 and 34, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Gly).
The residues at positions 4 and 5, specifically D and G, respectively, take part in an intrachain covalent linkage referred to as (2-aminosuccinimidyl)acetic acid (Asp-Gly); alternate.
The residues at positions 4 and 5, specifically D and G, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Asp-Gly); alternate.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 381.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 388.
The residues at positions 105 and 226, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-252).
The residues at positions 226 and 252, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-105).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 22.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 22.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 376.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 376.
The residues at positions 121 and 244, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-270).
The residues at positions 244 and 270, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-121).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 188.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 143.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 148.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 298.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 304.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 466.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 264.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 298.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 298.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 79.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 354.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 676.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 530.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 496.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 10.
The residues at positions 1 and 31, specifically S and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Asn).
The residues at positions 1 and 31, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 166.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 368.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 6.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 219.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 170.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 186.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 325.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 779.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 908.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 916.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3), involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 213.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 38.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 41.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 78.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 47.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 196.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 214.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 242.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 72.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 158.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 78.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 141.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 152.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 160.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 190.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 199.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 285.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 302.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 869.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 869.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 882.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 84.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 94.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 130.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 175.
The establishment of interchain covalent linkage, termed (Microbial infection) Isoglutamyl lysine isopeptide (Lys-Glu) (interchain with E-270); by Vibrio toxins RtxA and VgrG1, involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed (Microbial infection) Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-50); by Vibrio toxins RtxA and VgrG1, involves the residue E present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 734.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 963.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 318.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 91.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 309.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 390.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 435.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 469.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 524.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 534.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 544.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 577.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 620.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 687.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 700.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 721.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 738.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 758.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 792.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 824.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 921.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1335.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1403.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1406.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1460.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1742.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1869.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 165.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 165.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 488.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 500.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 500.
The residues at positions 91 and 214, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-240).
The residues at positions 214 and 240, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 62.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 101.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 192.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 200.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 245.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 373.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 219.
The residues at positions 1 and 29, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 71 and 162, specifically V and Y, respectively, take part in an intrachain covalent linkage referred to as 3-(O4'-tyrosyl)-valine (Val-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 146.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 171.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 262.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 281.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 307.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 119.
The residues at positions 241 and 245, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 48.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 97.
The residues at positions 243 and 247, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Peptide (Met-Gly) (interchain with G-Cter in ubiquitin), involves the residue M present at position 1.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 93.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 541.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1029.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 3.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 179.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 183.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 350.
The residues at positions 1 and 31, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 120.
The residues at positions 89 and 212, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-238).
The residues at positions 212 and 238, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-89).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 17.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 103.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 400.
The residues at positions 2 and 8, specifically A and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ala-Pro).
The residues at positions 3 and 7, specifically W and C, respectively, take part in an intrachain covalent linkage referred to as 2'-cysteinyl-6'-hydroxytryptophan sulfoxide (Trp-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 58.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 67.
The residues at positions 494 and 529, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The residues at positions 1000 and 1003, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 1 and 32, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 96 and 219, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-245).
The residues at positions 219 and 245, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 11.
The residues at positions 265 and 269, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 6.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 135.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 600.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 284.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3), involves the residue K present at position 465.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 406.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 112.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 127.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 447.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 459.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 472.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 131.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 314.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 162.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 225.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 197.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 197.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 46.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 161.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 894.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1056.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1063.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1340.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1415.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 190.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 175.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 246.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 378.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 557.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 223.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 224.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 648.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin; alternate), involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 269.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 72.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 197.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 292.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 302.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 467.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 467.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 170.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 550.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 355.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 154.
The residues at positions 96 and 224, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-250).
The residues at positions 224 and 250, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 639.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 772.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 773.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 233.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 254.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1086.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 121.
The residues at positions 15 and 19, specifically E and Y, respectively, take part in an intrachain covalent linkage referred to as Pyrroloquinoline quinone (Glu-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 223.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 54.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 788.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 444.
The residues at positions 92 and 220, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-246).
The residues at positions 220 and 246, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 242.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 253.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 393.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 284.
The residues at positions 88 and 211, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-237).
The residues at positions 211 and 237, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-88).
The residues at positions 1 and 30, specifically S and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 85.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 95.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 131.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 227.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 575.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 634.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 678.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 580.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 244.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 263.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 230.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 120.
The residues at positions 70 and 99, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 398.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 464.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 9.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 234.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 278.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 415.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 589.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 594.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 602.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 633.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 646.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 652.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 656.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 666.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 678.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 682.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 688.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 704.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 710.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 720.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 344.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 389.
The residues at positions 102 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-102).
The residues at positions 73 and 105, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 168 and 200, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 318.
The residues at positions 921 and 924, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 22.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 127.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 305.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 352.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 352.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 527.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 527.
The residues at positions 85 and 149, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 248.
The residues at positions 98 and 226, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-252).
The residues at positions 226 and 252, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 60.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 198.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 467.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 586.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 646.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 695.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1053.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1147.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1147.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1233.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 242.
The residues at positions 1166 and 1169, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 82.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 248.
The residues at positions 38 and 45, specifically G and E, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl glycine isopeptide (Gly-Glu).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 39.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 47.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 57.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 54.
The residues at positions 92 and 238, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-264).
The residues at positions 238 and 264, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 405.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 419.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 745.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 433.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 433.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 689.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 878.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 927.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 973.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 148.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 178.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 441.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 335.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 391.
The residues at positions 8 and 12, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 102.
The residues at positions 93 and 157, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 75.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 77.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 288.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 420.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 539.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 583.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 645.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 704.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 704.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 729.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 746.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 815.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 843.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 849.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 947.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 988.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 989.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 17.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 303.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 361.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 376.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 414.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 423.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 424.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 435.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 484.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 769.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1450.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 569.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 688.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 34.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 34.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 219.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 405.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 422.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 422.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 422.
The residues at positions 42 and 50, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 235.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 62.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 22.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 59.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 565.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 334.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 408.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 473.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 487.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 253.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 367.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 308.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 331.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 244.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 363.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1862.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1863.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2079.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 794.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 802.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 884.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 884.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1394.
The residues at positions 194 and 196, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 676.
The residues at positions 5 and 9, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 394.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 255.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 446.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 628.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 252.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 263.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 510.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 655.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 56.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 61.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 489.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 430.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 184.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 398.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 43.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 567.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 120.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 290.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 384.
The residues at positions 12 and 14, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 247 and 249, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 573.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 338.
The residues at positions 239 and 243, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 469.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 472.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 186.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 540.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 605.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 229.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 13.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 305.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 56.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 499.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 542.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 143.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 31.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 6.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 29.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 33.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 36.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 615.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 754.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 763.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 804.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 814.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 821.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 850.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 857.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 923.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 964.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 969.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 977.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 981.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 991.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1017.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1026.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1135.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1183.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 161.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 385.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 80.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 80.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 377.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 442.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 623.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 623.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1004.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1488.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1982.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1982.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1987.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 762.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 83.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 462.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 465.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 545.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 786.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 80.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 252.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 560.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Gly-Cys) (interchain with C-192 in TtuC); alternate, involves the residue G present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 526.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 560.
The residues at positions 106 and 228, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-254).
The residues at positions 228 and 254, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-106).
The residues at positions 26 and 56, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 404.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 417.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 152.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 787.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 873.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1417.
The residues at positions 198 and 200, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 227.
The residues at positions 250 and 254, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The residues at positions 95 and 218, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-244).
The residues at positions 218 and 244, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-95).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 103.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 94.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 449.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 534.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 90.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 3.
The residues at positions 280 and 284, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed N5-[4-(S-L-cysteinyl)-5-methyl-1H-imidazol-2-yl]-L-ornithine (Arg-Cys) (interchain with C-151 in KEAP1), involves the residue R present at position 135.
The establishment of interchain covalent linkage, termed N5-[4-(S-L-cysteinyl)-5-methyl-1H-imidazol-2-yl]-L-ornithine (Cys-Arg) (interchain with R-135 in KEAP1), involves the residue C present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 58.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 49.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 49.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 348.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 95.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 448.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 300.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 86.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 130.
The residues at positions 91 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-253).
The residues at positions 227 and 253, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 40.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 76.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 77.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 87.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 102.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 103.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 376.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 582.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 520.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 543.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 778.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 784.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 789.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 791.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 791.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 808.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 808.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 876.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 968.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1022.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1072.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 290.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 29.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 457.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 474.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 737.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 755.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 766.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 766.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 825.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 877.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 879.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 925.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 937.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 965.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1003.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1012.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1030.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1040.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1070.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 1192.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1192.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 1201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 352.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 899.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 972.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 986.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 990.
The residues at positions 97 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-97).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 101.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 101.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 380.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 314.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 19.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 583.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 583.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 710.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 826.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 833.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 376.
The residues at positions 144 and 146, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 100.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 392.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 597.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 84.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 85.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 463.
The residues at positions 98 and 219, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-245).
The residues at positions 219 and 245, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The residues at positions 108 and 231, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-257).
The residues at positions 231 and 257, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-108).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 247.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 741.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 33.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 34.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 367.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 439.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 635.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 643.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 676.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 712.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1092.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1214.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1227.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1262.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1323.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1398.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1440.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1456.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1490.
The residues at positions 5 and 64, specifically L and L, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Leu).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 218.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 354.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 385.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 853.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 881.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 981.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1154.
The residues at positions 1 and 29, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 74.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 403.
The residues at positions 95 and 217, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-243).
The residues at positions 217 and 243, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-95).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 754.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 864.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 869.
The residues at positions 91 and 218, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-244).
The residues at positions 218 and 244, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 43.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 44.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 180.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 183.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 184.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1699.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1766.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1766.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1822.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 441.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 554.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 101.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 462.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 773.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 779.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 779.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 784.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 800.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 465.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 213.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 216.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 281.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 454.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 466.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 714.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 70.
The residues at positions 67 and 95, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 121 and 149, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 175 and 203, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 689.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 364.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 601.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 429.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 506.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 348.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 12.
The residues at positions 61 and 64, specifically C and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-D-cysteine (Cys-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 61.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 103.
The residues at positions 168 and 170, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 720.
The residues at positions 104 and 226, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-252).
The residues at positions 226 and 252, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-104).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 13.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1); alternate, involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 60.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 160.
The residues at positions 1441 and 1444, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 1 and 8, specifically I and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ile-Pro).
The residues at positions 2 and 6, specifically W and C, respectively, take part in an intrachain covalent linkage referred to as 2'-cysteinyl-6'-hydroxytryptophan sulfoxide (Trp-Cys).
The residues at positions 90 and 244, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-270).
The residues at positions 244 and 270, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-90).
The residues at positions 11 and 18, specifically I and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ile-Pro).
The residues at positions 12 and 16, specifically W and C, respectively, take part in an intrachain covalent linkage referred to as 2'-cysteinyl-6'-hydroxytryptophan sulfoxide (Trp-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 252.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 253.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 256.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 307.
The residues at positions 1 and 18, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 4 and 14, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 5 and 11, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 6 and 19, specifically S and K, respectively, take part in an intrachain covalent linkage referred to as Lysinoalanine (Ser-Lys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 831.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 754.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 326.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 370.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 882.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 246.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 285.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 292.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 302.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 309.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 309.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 321.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 325.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 189.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 480.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 652.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 796.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 816.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 962.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 620.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 406.
The residues at positions 96 and 242, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-268).
The residues at positions 242 and 268, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 427.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 545.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 198.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 508.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 756.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 901.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 931.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 216.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 360.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 475.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 523.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 549.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 587.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 704.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 742.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 778.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 798.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 870.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 891.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 958.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1014.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 247.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 264.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 382.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 421.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 859.
The residues at positions 143 and 145, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 82.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 232.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 349.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 74.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 697.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 483.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 514.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 388.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 388.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 531.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 43.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 404.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 548.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 571.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 581.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 607.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 610.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 619.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 621.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 166.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 171.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 88.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 519.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 147.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 102.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 77.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 91.
The residues at positions 94 and 155, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 290.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 747.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 759.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 828.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 831.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 529.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO; alternate), involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 357.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 659.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 661.
The residues at positions 117 and 181, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 517.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 508.
The residues at positions 279 and 283, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 44.
The residues at positions 203 and 205, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1120.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 687.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 269.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-148 in ATG5), involves the residue G present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 419.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 703.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 255.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 562.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1740.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1790.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1840.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1840.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 187.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 870.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 870.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 883.
The residues at positions 120 and 184, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 730.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 808.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 528.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 886.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 746.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 518.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 536.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 541.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 478.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 390.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 447.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 990.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 42.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 79.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 163.
The residues at positions 112 and 163, specifically W and W, respectively, take part in an intrachain covalent linkage referred to as Tryptophan tryptophylquinone (Trp-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 296.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1667), involves the residue M present at position 1549.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1549), involves the residue K present at position 1667.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 72.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 75.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 75.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 602.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP3), involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP3), involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP3), involves the residue K present at position 62.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 92.
The residues at positions 1 and 29, specifically A and R, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ala-Arg).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 386.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 388.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 501.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 553.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 75.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 169.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 220.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 420.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 481.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 37.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1161.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 755.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 86.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 666.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 224.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 411.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 694.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue Q present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 705.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 785.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1455.
The residues at positions 287 and 291, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1402.
The residues at positions 11 and 17, specifically A and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ala-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 137.
The residues at positions 146 and 148, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 36.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 49.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 80.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 323.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 286.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 407.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 407.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 409.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 409.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 628.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 166.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 88.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 579.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 829.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 955.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 60.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 225.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 429.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 567.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 568.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 585.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 650.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 658.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 212.
The residues at positions 45 and 49, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 53 and 63, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 64 and 69, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 66 and 73, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 774.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 416.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 34.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 230.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 254.
The residues at positions 264 and 268, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 433.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-138 in ATG5), involves the residue G present at position 93.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 81.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 255.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1673), involves the residue M present at position 1555.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1555), involves the residue K present at position 1673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 218.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 59.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 95.
The residues at positions 130 and 132, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1170.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1173.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 379.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 180.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 287.
The residues at positions 143 and 145, specifically C and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Cys-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 374.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 357.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 422.
The residues at positions 1 and 30, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 120.
The residues at positions 30 and 35, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 32 and 46, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 45 and 47, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 233.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 269.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 505.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 505.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 617.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 656.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 812.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 902.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 288.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 333.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 343.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 346.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 366.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 423.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 337.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 482.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 529.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 752.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 272.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 728.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 759.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 791.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 292.
The residues at positions 39 and 44, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 41 and 55, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 48 and 56, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 83 and 85, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 797.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 881.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 9.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 33.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 147.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 148.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 54.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 548.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 88.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 331.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 410.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 449.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 458.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 553.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 577.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 93.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 219.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 326.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 394.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 434.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 521.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 709.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 884.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 897.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1010.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1043.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1057.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1078.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1180.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1441.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 2468.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 261.
The residues at positions 90 and 213, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-239).
The residues at positions 213 and 239, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-90).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 57.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 701.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 112.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 152.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 193.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 510.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 529.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 82.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 173.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3), involves the residue K present at position 509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 626.
The residues at positions 91 and 245, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-271).
The residues at positions 245 and 271, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 11 and 17, specifically S and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 130.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 197.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 295.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 325.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 393.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 472.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 472.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 200.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 343.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 417.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 193.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 583.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 719.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 61.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 623.
The residues at positions 1010 and 1013, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 502.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 576.
The residues at positions 46 and 51, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 52 and 57, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 54 and 62, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 59 and 64, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine sulfoxide (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 370.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 377.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 513.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 577.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 589.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 589.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 624.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1175.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1198.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1291.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1309.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 134.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 500.
The residues at positions 202 and 204, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 76.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 31.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 224.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 286.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 366.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 45.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 291.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 291.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 386.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 36.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 127.
The residues at positions 113 and 173, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 521.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3); alternate, involves the residue K present at position 492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 559.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 190.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 538.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 609.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 762.
The residues at positions 91 and 215, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-241).
The residues at positions 215 and 241, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 107 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-255).
The residues at positions 229 and 255, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-107).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 61.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 365.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 260.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 459.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 256.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue C present at position 215.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 443.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 519.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 654.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 739.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 918.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 987.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1079.
The residues at positions 217 and 219, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 189.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 356.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 362.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 330.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 719.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 521.
The residues at positions 107 and 228, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-254).
The residues at positions 228 and 254, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-107).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 637.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 133.
The residues at positions 38 and 47, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as 3-hydroxypyridine-2,5-dicarboxylic acid (Ser-Ser) (with C-46).
The residues at positions 38 and 46, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as 3-hydroxypyridine-2,5-dicarboxylic acid (Ser-Cys) (with S-47).
The residues at positions 38 and 39, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The residues at positions 41 and 42, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Thr-Cys).
The residues at positions 43 and 45, specifically E and C, respectively, take part in an intrachain covalent linkage referred to as 2-(cystein-S-ylcarbonyl)-3-methyl-4-(glutam-5-yloxy)methylindole (Glu-Cys).
The residues at positions 43 and 44, specifically E and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Glu-Cys).
The residues at positions 45 and 46, specifically C and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Cys-Cys).
The residues at positions 47 and 48, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 481.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 481.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 612.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 29.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 29.
The residues at positions 24 and 31, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 34 and 41, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 291.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 347.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 835.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 970.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1081.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1093.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1112.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1169.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1179.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1575.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1576.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1657.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 362.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 292.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 758.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 366.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 566.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 337.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3); alternate, involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 428.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1035.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1061.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1080.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 214.
The residues at positions 97 and 220, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-246).
The residues at positions 220 and 246, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-97).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 171.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 445.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 506.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 507.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 736.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 740.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 222.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 440.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 452.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 235.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 13.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 653.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 672.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 424.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 424.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 254.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 188.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 56.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 99.
The residues at positions 151 and 153, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 538.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 81.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 97.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 158.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 193.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 877.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 972.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 100.
The residues at positions 246 and 250, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 334.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 334.
The residues at positions 247 and 251, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-187 in atg5), involves the residue G present at position 124.
The residues at positions 91 and 241, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-267).
The residues at positions 241 and 267, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 502.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 47.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 331.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 750.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 806.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 813.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 834.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 915.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 971.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 976.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 984.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 998.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1024.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1033.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1190.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 368.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 368.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form BTD-4, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form BTD-4, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 732.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 90.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 550.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 262.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 298.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 40.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 44.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 395.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 425.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 83.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 29.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 198.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 383.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 312.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 498.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 539.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 609.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 638.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 644.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 787.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 102.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 102.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 536.
The establishment of interchain covalent linkage, termed Glycyl cysteine dithioester (Cys-Gly) (interchain with G-Cter in ThiS), involves the residue C present at position 184.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 364.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 25.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-41 in alpha-2-antiplasmin), involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 347.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 385.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 527.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 558.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 575.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 581.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 453.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 475.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 403.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 115.
The residues at positions 43 and 49, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1 and SUMO2), involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-162), involves the residue Q present at position 31.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-31), involves the residue K present at position 162.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 422.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 499.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 74.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 456.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 476.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 476.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 179.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 345.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 200.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 740.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 781.
The residues at positions 112 and 240, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-266).
The residues at positions 240 and 266, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-112).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 599.
The residues at positions 16 and 20, specifically E and Y, respectively, take part in an intrachain covalent linkage referred to as Pyrroloquinoline quinone (Glu-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 1567.
The residues at positions 23 and 36, specifically Y and Y, respectively, take part in an intrachain covalent linkage referred to as Isodityrosine (Tyr-Tyr).
The residues at positions 972 and 975, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 563.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 603.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 665.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 963.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 963.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 101.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in other proteins), involves the residue Q present at position 693.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in other proteins), involves the residue Q present at position 694.
The residues at positions 148 and 270, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-296).
The residues at positions 270 and 296, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-148).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 65.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 363.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 108.
The residues at positions 184 and 198, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 593.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 615.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 615.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 885.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 913.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 93.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1032.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1032.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1038.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1069.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 635.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 317.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 488.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 488.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 750.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 750.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 19.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1302.
The residues at positions 29 and 58, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 365.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 516.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 581.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 36.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 98.
The residues at positions 655 and 691, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 319.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 515.
The residues at positions 1 and 31, specifically D and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Asp-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 693.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 770.
The residues at positions 101 and 248, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-274).
The residues at positions 248 and 274, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-101).
The residues at positions 26 and 34, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 187.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-163 in atg5), involves the residue G present at position 174.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 57.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 57.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1274.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 330.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 337.
The residues at positions 30 and 55, specifically C and I, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Cys-Ile).
The residues at positions 33 and 41, specifically C and M, respectively, take part in an intrachain covalent linkage referred to as 2-(S-cysteinyl)-methionine (Cys-Met).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 126.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1022.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 589.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 555.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1695.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1710.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1725.
The residues at positions 258 and 262, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 436.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 90.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 214.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 594.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 41.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 347.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 621.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 944.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 971.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1071.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1199.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 2091.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 674.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 481.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 513.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 718.
The residues at positions 984 and 987, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 573.
The residues at positions 11 and 19, specifically H and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (His-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 840.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 886.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 943.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 178.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 178.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 51.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1196.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 361.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 786.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 625.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 156.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 356.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 356.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 402.
The residues at positions 64 and 123, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 471.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 2.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?), involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 98.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 70.
The residues at positions 653 and 689, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 760.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 511.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 527.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 747.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 747.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 173.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 9.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 598.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-102 in ATG5), involves the residue G present at position 160.
The residues at positions 1 and 29, specifically H and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (His-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 660.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 506.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 651.
The residues at positions 1438 and 1441, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 49 and 50, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 52 and 60, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 61 and 66, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 63 and 68, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-3-methyl-D-cysteine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 839.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 62.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1002.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1452.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 453.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 868.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 868.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 930.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1365.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1434.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1434.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1563.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1563.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 364.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 220.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 220.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 732.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 774.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 846.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 12.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 464.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 586.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 640.
The residues at positions 144 and 146, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ser-Gly).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 415.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 467.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 504.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 504.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 396.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 430.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 430.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 67.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form BTD-7, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form BTD-7, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 630.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 471.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 548.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1178.
The residues at positions 67 and 95, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The residues at positions 121 and 149, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The residues at positions 175 and 203, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 433.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 272.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 142.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 194.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 132.
The residues at positions 11 and 19, specifically G and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 861.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 375.
The residues at positions 11 and 20, specifically L and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 873.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 968.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 571.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 693.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 623.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 340.
The residues at positions 66 and 68, specifically Q and G, respectively, take part in an intrachain covalent linkage referred to as 2-iminomethyl-5-imidazolinone (Gln-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 98.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 857.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 860.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 13.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 146.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 41.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 691.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 735.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 783.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 875.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 610.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 749.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 760.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 822.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 832.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 492.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 549.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 513.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 141.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 141.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 12.
The residues at positions 35 and 39, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 50 and 53, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 52 and 59, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 110 and 172, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 60.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 186.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 632.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 713.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 866.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 866.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 491.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 809.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 860.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 618.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 618.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1824.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1874.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1924.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1924.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 227.
The residues at positions 39 and 40, specifically G and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Gly-Ser).
The residues at positions 40 and 41, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The residues at positions 47 and 48, specifically G and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Gly-Cys).
The residues at positions 50 and 51, specifically G and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Gly-Cys).
The residues at positions 54 and 55, specifically G and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Gly-Cys).
The residues at positions 55 and 56, specifically C and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Cys-Ser).
The residues at positions 61 and 62, specifically G and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Gly-Ser).
The residues at positions 64 and 65, specifically G and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Gly-Ser).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 275.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 71.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 161.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 161.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 165.
The residues at positions 284 and 288, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 636.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 668.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 696.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 189.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-168 in ATG5), involves the residue G present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 81.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 156.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 396.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 33.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 494.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 15.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 420.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 420.
The residues at positions 325 and 348, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3-(S-cysteinyl)-tyrosine (Cys-Tyr).
The residues at positions 98 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-254).
The residues at positions 227 and 254, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in smo-1), involves the residue K present at position 342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 100.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 819.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 901.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 901.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1425.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 733.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 917.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 91.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 298.
The residues at positions 988 and 991, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1701.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1716.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1731.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 148.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-128 in ATG5), involves the residue G present at position 94.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 102.
The residues at positions 10 and 14, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The residues at positions 91 and 242, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-268).
The residues at positions 242 and 268, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 207 and 330, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-356).
The residues at positions 330 and 356, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-207).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 474.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 689.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 100.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 314.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 4.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 67.
The residues at positions 95 and 241, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-267).
The residues at positions 241 and 267, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-95).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 300.
The residues at positions 27 and 31, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 32 and 35, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 37 and 43, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 47 and 50, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 49 and 52, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 134.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 134.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 132.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 56.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 166.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 315.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 327.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 495.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 752.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 752.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 346.
The residues at positions 94 and 154, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 15 and 16, specifically C and F, respectively, take part in an intrachain covalent linkage referred to as N,N-(cysteine-1,S-diyl)phenylalanine (Cys-Phe); alternate.
The residues at positions 95 and 224, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-250).
The residues at positions 224 and 250, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-95).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 330.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 628.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 631.
The residues at positions 91 and 243, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-269).
The residues at positions 243 and 269, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 647.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 662.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 823.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 854.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 874.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 956.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 173.
The residues at positions 112 and 239, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-265).
The residues at positions 239 and 265, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-112).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 503.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 507.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 608.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 177.
The residues at positions 1 and 32, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 158.
The residues at positions 179 and 196, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 414.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 592.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 600.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 600.
The residues at positions 66 and 68, specifically K and G, respectively, take part in an intrachain covalent linkage referred to as 2-tetrahydro-2-pyridyl-5-imidazolinone (Lys-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 559.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 382.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 547.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 663.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 685.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 735.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 760.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 800.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 844.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1018.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1152.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1184.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 187.
The residues at positions 109 and 231, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-257).
The residues at positions 231 and 257, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-109).
The residues at positions 82 and 207, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-233).
The residues at positions 207 and 233, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-82).
The residues at positions 93 and 221, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-247).
The residues at positions 221 and 247, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-93).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 42.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 42.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 351.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 619.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 666.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 765.
The residues at positions 96 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The residues at positions 209 and 211, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 682.
The residues at positions 25 and 53, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 557.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 419.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 419.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 164.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 525.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 578.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 785.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 738.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 101.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 533.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 546.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 596.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 625.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 38.
The residues at positions 108 and 172, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 134.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 525.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 156.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 21.
The residues at positions 970 and 973, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 95 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-95).
The residues at positions 249 and 253, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 858.
The residues at positions 157 and 222, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 407.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 286.
The residues at positions 110 and 233, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-259).
The residues at positions 233 and 259, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-110).
The residues at positions 143 and 145, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ser-Gly).
The residues at positions 1 and 29, specifically G and R, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Arg).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 306.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 379.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 379.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 409.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 555.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 555.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 677.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 751.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 751.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 751.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 771.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 775.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 780.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 780.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 805.
The residues at positions 185 and 202, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 95.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 261.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 81.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1411.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 561.
The residues at positions 91 and 244, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-270).
The residues at positions 244 and 270, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 117 and 180, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 644 and 680, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 715.
The residues at positions 120 and 182, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 86.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 757.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 803.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 851.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 932.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 120.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 223.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 445.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 445.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 63.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 47.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 609.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1409.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 398.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 949.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3), involves the residue K present at position 205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1589.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form BTD-1, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit B); in form BTD-2, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form BTD-1, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit B); in form BTD-2, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 657.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-154); alternate, involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-216); alternate, involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-89), involves the residue Q present at position 154.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-312), involves the residue Q present at position 212.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-312), involves the residue Q present at position 213.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-89), involves the residue Q present at position 216.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-212); alternate, involves the residue K present at position 312.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-213); alternate, involves the residue K present at position 312.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 707.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 847.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 948.
The residues at positions 11 and 20, specifically I and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ile-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 861.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 103.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1749.
The residues at positions 1 and 9, specifically C and D, respectively, take part in an intrachain covalent linkage referred to as 3-cysteinyl-aspartic acid (Cys-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 723.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 743.
The residues at positions 35 and 40, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 37 and 47, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 43 and 48, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 173.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 59.
The residues at positions 28 and 29, specifically R and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Arg-Cys).
The residues at positions 29 and 30, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as 5-methyloxazole-4-carboxylic acid (Cys-Thr).
The residues at positions 30 and 31, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Thr-Cys).
The residues at positions 31 and 32, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as 5-methyloxazole-4-carboxylic acid (Cys-Thr).
The residues at positions 32 and 33, specifically T and T, respectively, take part in an intrachain covalent linkage referred to as 5-methyloxazole-4-carboxylic acid (Thr-Thr).
The residues at positions 35 and 36, specifically I and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Ile-Ser).
The residues at positions 36 and 37, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Ser-Ser).
The residues at positions 37 and 38, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Ser-Ser).
The residues at positions 38 and 39, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as Oxazole-4-carboxylic acid (Ser-Ser).
The residues at positions 39 and 40, specifically S and T, respectively, take part in an intrachain covalent linkage referred to as 5-methyloxazoline-4-carboxylic acid (Ser-Thr).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 334.
The residues at positions 76 and 104, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 498.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 312.
The residues at positions 98 and 234, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-260).
The residues at positions 234 and 260, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 252.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 333.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 346.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 448.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 448.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 452.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 468.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 524.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 706.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 708.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 753.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 872.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 493.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-218 in ATG5), involves the residue G present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 393.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 360.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 94.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 19.
The residues at positions 33 and 37, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 44 and 52, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 47 and 53, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 55 and 58, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 59 and 62, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 94.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 532.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1034.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 205.
The residues at positions 1 and 30, specifically K and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Lys-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2449.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-129 in atg-5), involves the residue G present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 80.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 532.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 669.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 751.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 30.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 38.
The residues at positions 90 and 92, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 126 and 248, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-274).
The residues at positions 248 and 274, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-126).
The residues at positions 98 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The residues at positions 29 and 59, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 463.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 565.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-159 in ATG5), involves the residue G present at position 130.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 51.
The residues at positions 33 and 37, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 38 and 41, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 49 and 52, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-D-cysteine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 496.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 821.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 823.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 239.
The residues at positions 113 and 164, specifically W and W, respectively, take part in an intrachain covalent linkage referred to as Tryptophan tryptophylquinone (Trp-Trp).
The residues at positions 201 and 203, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 397.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1127.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1127.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 90.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 625.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 627.
The residues at positions 949 and 952, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 148.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 646.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1227.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 347.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 347.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 384.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 394.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 411.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 614.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 175.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 432.
The residues at positions 210 and 212, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 91.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 703.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 319.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 453.
The residues at positions 91 and 236, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-262).
The residues at positions 236 and 262, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 52 and 55, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM1.
The residues at positions 58 and 68, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM1.
The residues at positions 69 and 74, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM1.
The residues at positions 71 and 78, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM1.
The residues at positions 36 and 40, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 55 and 61, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 63 and 66, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 67 and 70, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1853.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1020.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue C present at position 280.
The residues at positions 98 and 222, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-248).
The residues at positions 222 and 248, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 660.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 247.
The residues at positions 145 and 147, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 160.
The residues at positions 1 and 28, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 76 and 167, specifically V and Y, respectively, take part in an intrachain covalent linkage referred to as 3-(O4'-tyrosyl)-valine (Val-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 246.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 246.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 248.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 255.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 261.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 261.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 388.
The residues at positions 147 and 149, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 260 and 264, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 72.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1470.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1644.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 501.
The residues at positions 401 and 405, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 307.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 278.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 356.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 674.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 637.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 535.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 558.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 568.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 594.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 597.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 606.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 608.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 716.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 737.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 867.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 929.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 970.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue C present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1141.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 56.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 570.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 578.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 578.
The residues at positions 113 and 236, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-262).
The residues at positions 236 and 262, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-113).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 791.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 22.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 684.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 714.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 817.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 92.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 837.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 848.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1055.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1134.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1186.
The residues at positions 206 and 208, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 671.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 165.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 40.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1141.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1163.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1662.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 614.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1075.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1228.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1286.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1363.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1367.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1373.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1424.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1461.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1494.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 229.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 675.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1043.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1043.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 473.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 528.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 647.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1246.
The residues at positions 200 and 202, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 104 and 106, specifically Q and G, respectively, take part in an intrachain covalent linkage referred to as 2-iminomethyl-5-imidazolinone (Gln-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1194.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 326.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 326.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 515.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 579.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 895.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2443.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1008.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 617.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 623.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 533.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 43.
The residues at positions 44 and 48, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 57 and 62, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 60 and 63, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-D-cysteine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 2114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 51.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in TtuB), involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in TtuB), involves the residue K present at position 226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in TtuB), involves the residue K present at position 229.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 127.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 535.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1242.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 629.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 471.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 915.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 955.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 342.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 926.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 180.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 180.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in MoaD), involves the residue K present at position 119.
The residues at positions 90 and 238, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-264).
The residues at positions 238 and 264, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-90).
The residues at positions 180 and 194, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 106 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-255).
The residues at positions 229 and 255, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-106).
The residues at positions 94 and 222, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-248).
The residues at positions 222 and 248, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-94).
The residues at positions 11 and 18, specifically G and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Pro).
The residues at positions 116 and 244, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-270).
The residues at positions 244 and 270, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-116).
The residues at positions 923 and 926, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 922.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 178.
The residues at positions 248 and 252, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 627.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-128 in ATG5), involves the residue G present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 722.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 994.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 46.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 158.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 320.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 494.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 494.
The residues at positions 244 and 248, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 839.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1423.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1696.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1762.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 686.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3), involves the residue K present at position 252.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 508.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 349.
The residues at positions 114 and 234, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-260).
The residues at positions 234 and 260, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-114).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 79.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 538.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 541.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 564.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 574.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 600.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 603.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 612.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 614.
The residues at positions 62 and 64, specifically Q and G, respectively, take part in an intrachain covalent linkage referred to as 2-iminomethyl-5-imidazolinone (Gln-Gly).
The residues at positions 100 and 222, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-248).
The residues at positions 222 and 248, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-100).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 604.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 604.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 657.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 657.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 658.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 743.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 743.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 797.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 797.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 910.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 938.
The residues at positions 128 and 250, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-276).
The residues at positions 250 and 276, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-128).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 335.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 567.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 841.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 304.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 377.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 469.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 469.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 554.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 554.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 750.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 770.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 774.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 779.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 804.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 804.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 93.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 55.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 123.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 296.
The residues at positions 236 and 240, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1P1/SUMO5), involves the residue K present at position 18.
The residues at positions 114 and 176, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Gly-Cys) (interchain with C-192 in TtuC); alternate, involves the residue G present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 65.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 421.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 421.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 575.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 607.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 666.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 698.
The residues at positions 986 and 989, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 867.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 892.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2025.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 498.
The residues at positions 688 and 724, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 330.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 813.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 618.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 711.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 711.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1239.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1304.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1528.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1529.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1565.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1584.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1606.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1617.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1636.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1643.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1647.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1660.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1687.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1865.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 78.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 230.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 307.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 588.
The residues at positions 197 and 214, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 450.
The residues at positions 92 and 109, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 724.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 118.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 699.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 878.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 503.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 538.
The residues at positions 63 and 65, specifically M and G, respectively, take part in an intrachain covalent linkage referred to as 2-iminomethyl-5-imidazolinone (Met-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 919.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 825.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 460.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 468.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 697.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor protein), involves the residue G present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 302.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 302.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 392.
The residues at positions 229 and 231, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1030.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1416.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 707.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); by NEDD4, involves the residue K present at position 1268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 379.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 503.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 828.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 830.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 306.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 334.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 381.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 9.
The residues at positions 204 and 206, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 35 and 57, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 713.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 752.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 295.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 537.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 37.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 58.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 533.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 539.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 455.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 558.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1324.
The residues at positions 101 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-253).
The residues at positions 227 and 253, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-101).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 564.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1473.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1965.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1965.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1970.
The residues at positions 109 and 171, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 188.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in URM1), involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 531.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 866.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1676.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1709.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 562.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 642.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 944.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 974.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 851.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 712.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 102.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 526.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 527.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 738.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 780.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 852.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1009.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1048.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 432.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1050.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1197.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1931.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 221.
The residues at positions 82 and 111, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3), involves the residue K present at position 37.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate, involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO3); alternate, involves the residue K present at position 123.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 119.
The residues at positions 69 and 161, specifically Y and C, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Tyr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 286.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 380.
The residues at positions 100 and 228, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-254).
The residues at positions 228 and 254, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-100).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 543.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 663.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 667.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 675.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 690.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 517.
The establishment of interchain covalent linkage, termed Dityrosine (Tyr-Tyr) (interchain with Y-372), involves the residue Y present at position 357.
The establishment of interchain covalent linkage, termed Dityrosine (Tyr-Tyr) (interchain with Y-357), involves the residue Y present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-158 in atg5), involves the residue G present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 222.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 222.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 504.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 832.
The residues at positions 113 and 183, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 260.
The residues at positions 116 and 238, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-264).
The residues at positions 238 and 264, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-116).
The residues at positions 34 and 44, specifically W and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Trp-Pro).
The residues at positions 52 and 62, specifically W and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Trp-Pro).
The residues at positions 70 and 80, specifically W and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Trp-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 361.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 26.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 90.
The residues at positions 1015 and 1018, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 96.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 260.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 21.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 122.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 553.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 553.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 553.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 79.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 66.
The establishment of interchain covalent linkage, termed Glycyl cysteine dithioester (Gly-Cys) (interchain with C-184 in ThiF); alternate, involves the residue G present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1044.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 305.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 378.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 378.
The residues at positions 89 and 117, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 197 and 199, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1008.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1046.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1364.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 721.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 721.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1222.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1246.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1308.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1573.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1585.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1876.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1971.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1988.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in other proteins), involves the residue Q present at position 496.
The residues at positions 1 and 30, specifically S and K, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Lys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 720.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 10.
The residues at positions 268 and 272, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 774.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1130.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1285.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 544.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 564.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 30.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 30.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 30.
The residues at positions 105 and 106, specifically N and G, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Asn-Gly); alternate.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-145 in ATG5), involves the residue G present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 533.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-162 in ATG5), involves the residue G present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 20.
The residues at positions 85 and 115, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 677.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 197.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 34.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 35.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 47.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 856.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 890.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 143.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 473.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 761.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 130.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 696.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 845.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 972.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 972.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-135 in ATG5), involves the residue G present at position 167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 535.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 681.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 696.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 745.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1146.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 74.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 75.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 77.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 77.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 301.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 348.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 348.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 519.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 519.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 812.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); in isoform Alpha, involves the residue K present at position 628.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 41.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 187.
The residues at positions 122 and 249, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-275).
The residues at positions 249 and 275, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-122).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1759.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 169.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 33.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 230.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 416.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 247.
The residues at positions 11 and 18, specifically F and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Phe-Pro).
The residues at positions 175 and 177, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 110 and 174, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 403.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 317.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 317.
The residues at positions 66 and 68, specifically N and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Asn-Gly).
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1650), involves the residue M present at position 1532.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1532), involves the residue K present at position 1650.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 999.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1034.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1057.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-145 in ATG5), involves the residue G present at position 189.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 562.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 425.
The residues at positions 40 and 53, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 474.
The residues at positions 20 and 21, specifically L and C, respectively, take part in an intrachain covalent linkage referred to as 2-(3-methylbutanoyl)-5-hydroxyoxazole-4-carbothionic acid (Leu-Cys).
The residues at positions 26 and 27, specifically P and C, respectively, take part in an intrachain covalent linkage referred to as Proline 5-hydroxy-oxazole-4-carbothionic acid (Pro-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 807.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1042.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 56.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1403.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 875.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 72.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 683.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 782.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 862.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 603.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 764.
The residues at positions 68 and 72, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 77 and 81, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 836.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1336.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 775.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1820.
The residues at positions 5 and 8, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 97 and 219, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-245).
The residues at positions 219 and 245, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-97).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 1570.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 385.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 512.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 837.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 486.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 218.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 301.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 352.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Glu) (interchain with E-272); by Vibrio toxins RtxA and VgrG1, involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-52); by Vibrio toxins RtxA and VgrG1, involves the residue E present at position 272.
The residues at positions 76 and 79, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 78 and 82, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 81 and 90, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 724.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 795.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 818.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 230.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 103.
The residues at positions 79 and 81, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 661.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-160 in ATG5), involves the residue G present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 807.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 169.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 52.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 341.
The residues at positions 34 and 38, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 40 and 43, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 42 and 45, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 46 and 49, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 48 and 52, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 269.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 838.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor protein), involves the residue G present at position 141.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 565.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 84.
The residues at positions 37 and 41, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1405.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 725.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1028.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 692.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 717.
The residues at positions 109 and 160, specifically W and W, respectively, take part in an intrachain covalent linkage referred to as Tryptophan tryptophylquinone (Trp-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 626.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 627.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 199.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 496.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 149.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 2005.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 711.
The residues at positions 199 and 201, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 704.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 485.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 718.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 739.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 756.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 869.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 931.
The residues at positions 191 and 193, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-130 in ATG5), involves the residue G present at position 140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 193.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 360.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 366.
The residues at positions 192 and 209, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 137.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 325.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 368.
The residues at positions 94 and 217, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-243).
The residues at positions 217 and 243, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-94).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 263.
The residues at positions 999 and 1002, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 908.
The residues at positions 102 and 178, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 87.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3); alternate, involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 563.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 374.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-431), involves the residue Q present at position 423.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-423), involves the residue K present at position 431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 630.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 370.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 911.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 225.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1103.
The residues at positions 103 and 226, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-252).
The residues at positions 226 and 252, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-103).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 405.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 934.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1558.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1566.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 203.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 207.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1232.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1297.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1521.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1522.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1558.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1577.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1609.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1620.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1639.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1646.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1650.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1663.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1690.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1868.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 891.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 776.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 682.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 686.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 694.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 709.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-128 in ATG5), involves the residue G present at position 96.
The residues at positions 72 and 200, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-226).
The residues at positions 200 and 226, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-72).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 520.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 559.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 44.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15); alternate, involves the residue K present at position 134.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 222.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 983.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 983.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1053.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1053.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1652.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651), involves the residue M present at position 1533.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1533), involves the residue K present at position 1651.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 822.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 825.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 771.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1095.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1095.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1207.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1270.
The residues at positions 19 and 21, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 161 and 163, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 75 and 85, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 78 and 82, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 242 and 246, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 429.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 147.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 271.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 262.
The residues at positions 6 and 7, specifically N and G, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Asn-Gly); alternate.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 450.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1010.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1158.
The residues at positions 253 and 255, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 156.
The residues at positions 11 and 18, specifically L and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 340.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 5.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 194.
The residues at positions 167 and 169, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Glu) (interchain with E-271); by Vibrio toxins RtxA and VgrG1, involves the residue K present at position 51.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-51); by Vibrio toxins RtxA and VgrG1, involves the residue E present at position 271.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 858.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 892.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 504.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1166.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 32.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 953.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 973.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1189.
The residues at positions 96 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-253).
The residues at positions 227 and 253, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 402.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 688.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 667.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 784.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 793.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 253.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 617.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 620.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 74.
The residues at positions 91 and 216, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-242).
The residues at positions 216 and 242, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 315.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 511.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1168.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1171.
The residues at positions 1 and 29, specifically S and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Ser-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 415.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 415.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 604.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 663.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 154.
The residues at positions 29 and 33, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 48 and 54, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 56 and 59, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 60 and 63, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 572.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1605.
The residues at positions 140 and 142, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 522.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 151.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 215.
The residues at positions 182 and 184, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-119 in MoaE), involves the residue G present at position 81.
The residues at positions 7 and 76, specifically L and W, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 960.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 907.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 730.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 734.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 539.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 545.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 553.
The residues at positions 314 and 349, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The residues at positions 259 and 263, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-144 in ATG5), involves the residue G present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 777.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 951.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 958.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 958.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 985.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1126.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1165.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1211.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1295.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1337.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1366.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1474.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1538.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1552.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1641.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 726.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1062.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 247.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 2094.
The residues at positions 186 and 188, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 974 and 977, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 514.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 574.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 586.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 621.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1548.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 6.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 525.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 602.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 716.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 865.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 914.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 929.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 936.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1036.
The residues at positions 93 and 241, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-267).
The residues at positions 241 and 267, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-93).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 18.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 515.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1080.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 895.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 631.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 235.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 70.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 248.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 348.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 351.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1007.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 858.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 861.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 636.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 334.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 636.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 90.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 487.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 487.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 66.
The residues at positions 3 and 7, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 8 and 11, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 16 and 21, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 19 and 22, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-D-cysteine (Ser-Cys).
The residues at positions 4 and 8, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1389.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1518.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 523.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 122.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1454.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 261.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 304.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 698.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 743.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 820.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 966.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 935.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1016.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1035.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1042.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 522.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 574.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 642.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 450.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 450.
The residues at positions 107 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-255); alternate.
The residues at positions 229 and 255, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-107); alternate.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2007.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1385.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1422.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1442.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1459.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1484.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 744.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 729.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 126.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 475.
The residues at positions 16 and 19, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 615.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 532.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 547.
The residues at positions 56 and 60, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 62 and 65, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 66 and 69, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 85.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 20.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 109.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 68.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 794.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 301.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 826.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 826.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1089.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1107.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 498.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 724.
The residues at positions 63 and 65, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 479 and 481, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 897 and 899, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 59.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 344.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 9.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 288.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 305.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 318.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 324.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 354.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 382.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 392.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 3.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 661.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 903.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 792.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 792.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 826.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 561.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 664.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 680.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 715.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 827.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 991.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 991.
The residues at positions 189 and 191, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 139 and 141, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 155.
The residues at positions 235 and 239, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 526.
The residues at positions 56 and 58, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 335.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 482.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 482.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 627.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 520.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 45.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 499.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 88.
The residues at positions 89 and 219, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-245).
The residues at positions 219 and 245, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-89).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-261 in ATG5), involves the residue G present at position 166.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1024.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1027.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 871.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 887.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1019.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1046.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1066.
The residues at positions 11 and 20, specifically F and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Phe-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 734.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 192.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 458.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 467.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 586.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 585.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 631.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1074.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1199.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1223.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1235.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1235.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1254.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1278.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1281.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1362.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1368.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1380.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1417.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1449.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1487.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 160.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 100.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 488.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 206.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 322.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 386.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 389.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 703.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 703.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 905.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 920.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 38.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 90.
The residues at positions 45 and 46, specifically A and N, respectively, take part in an intrachain covalent linkage referred to as Alanine isoaspartyl cyclopeptide (Ala-Asn); in form venom peptide 10.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1239.
The residues at positions 114 and 177, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 345.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 376.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 391.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 585.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 672.
The residues at positions 27 and 30, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 308.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 811.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 811.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 530.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 536.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 544.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 727.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 983.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 387.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 148.
The residues at positions 343 and 347, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 610.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 362.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 634.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 889.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 928.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1015.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1060.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1446.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 887.
The residues at positions 6 and 10, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 17.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 78.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 78.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 827.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 827.
The residues at positions 11 and 20, specifically Y and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Tyr-Pro).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 304.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 152.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 578.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 184.
The establishment of interchain covalent linkage, termed Glycyl serine ester (Ser-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue S present at position 353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 515.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 522.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 736.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 770.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 836.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 36.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 48.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 326.
The residues at positions 100 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-100).
The residues at positions 11 and 19, specifically V and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Val-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 181.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 218.
The residues at positions 927 and 1042, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 1082 and 1232, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 1259 and 1393, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 823.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1404.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1420.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 54.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 54.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 134.
The residues at positions 91 and 219, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-245).
The residues at positions 219 and 245, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-91).
The residues at positions 26 and 30, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 31 and 34, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 36 and 42, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 48 and 51, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 157 and 221, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The residues at positions 60 and 77, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 63 and 73, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 64 and 70, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Cys-Thr).
The residues at positions 65 and 78, specifically S and K, respectively, take part in an intrachain covalent linkage referred to as Lysinoalanine (Ser-Lys).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue C present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 690.
The residues at positions 634 and 670, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 952.
The residues at positions 99 and 227, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-253).
The residues at positions 227 and 253, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-99).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1034.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1034.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1741), involves the residue M present at position 1623.
The establishment of interchain covalent linkage, termed S-Lysyl-methionine sulfilimine (Lys-Met) (interchain with M-1623), involves the residue K present at position 1741.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-112 in ATG5), involves the residue G present at position 205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 424.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 708.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 377.
The residues at positions 108 and 170, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 281.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 281.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 698.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 698.
The residues at positions 29 and 37, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 205.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 355.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 427.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 427.
The residues at positions 113 and 238, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-264).
The residues at positions 238 and 264, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-113).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 198.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 296.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 151.
The residues at positions 49 and 54, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 57 and 65, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 62 and 67, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 472.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 374.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 40.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 40.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 879.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 879.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 116.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 116.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 355.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 816.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 816.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1155.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 215.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 330.
The residues at positions 77 and 200, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-226).
The residues at positions 200 and 226, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-77).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 6.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); in isoform Alpha, involves the residue K present at position 627.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1012.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1012.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1067.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-149 in ATG5), involves the residue G present at position 186.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 570.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 395.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 229.
The residues at positions 919 and 922, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 445.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 262.
The residues at positions 36 and 40, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by the dehydratase ElxB and the cyclase ElxC.
The residues at positions 44 and 47, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by the dehydratase ElxB and the cyclase ElxC.
The residues at positions 46 and 49, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by the dehydratase ElxB and the cyclase ElxC.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 114.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 267.
The residues at positions 11 and 17, specifically H and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (His-Pro).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 288.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 871.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1817.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1818.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2034.
The residues at positions 93 and 242, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-268).
The residues at positions 242 and 268, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-93).
The residues at positions 276 and 280, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 106.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 330.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 846.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 846.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 906.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 942.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 957.
The residues at positions 54 and 59, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 63 and 68, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 63.
The residues at positions 269 and 271, specifically C and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Cys-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 139.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 34.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 390.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1431.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1560.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1560.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 438.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 438.
The residues at positions 97 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-97).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 40.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1212.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 699.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 699.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-132 in APG5), involves the residue G present at position 111.
The residues at positions 331 and 333, specifically Y and C, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Tyr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 700.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 700.
The residues at positions 151 and 168, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 347.
The residues at positions 104 and 166, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 154.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 671.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 392.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 537.
The residues at positions 93 and 216, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-242).
The residues at positions 216 and 242, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-93).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 855.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 230.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 248.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 257.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 263.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 263.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1019.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1023.
The residues at positions 192 and 194, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3); alternate, involves the residue K present at position 591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 94.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-432), involves the residue Q present at position 424.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-424), involves the residue K present at position 432.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 819.
The residues at positions 1 and 28, specifically E and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Glu-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1315.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1427.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1443.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-157 in atg5), involves the residue G present at position 173.
The residues at positions 516 and 581, specifically C and W, respectively, take part in an intrachain covalent linkage referred to as 4'-cysteinyl-tryptophylquinone (Cys-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 397.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 354.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 196.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 44.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 23.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 53.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 63.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 184.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1128.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1148.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1236.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 780.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 901.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 171.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 201.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 260.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 341.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 763.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 769.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 776.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 776.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 793.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 793.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 953.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 649.
The residues at positions 118 and 241, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-267).
The residues at positions 241 and 267, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-118).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 207.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau, involves the residue K present at position 571.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 576.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 584.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 598.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 615.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau, involves the residue K present at position 628.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 634.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 638.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 648.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 660.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 664.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau, involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 686.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 692.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 702.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-147 in ATG5), involves the residue G present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1960.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 24.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 790.
The residues at positions 392 and 415, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-histidyl-3-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 333.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 216.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 339.
The residues at positions 978 and 981, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 109.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 541.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 975.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 149.
The residues at positions 122 and 244, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-270).
The residues at positions 244 and 270, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-122).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1193.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1238.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1272.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1279.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1359.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1382.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1438.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1480.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 209.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 570.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 592.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 609.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 632.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 642.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 654.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 658.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 664.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 680.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 696.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 270.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 314.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 314.
The residues at positions 68 and 70, specifically K and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Lys-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 425.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 55.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1051.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 898.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1349.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 556.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 76.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 186.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1260.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 37.
The residues at positions 185 and 199, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 23 and 27, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 28 and 31, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 635 and 671, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 308.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 308.
The residues at positions 1005 and 1008, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 399.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 502.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 537.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 722.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 309.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 309.
The residues at positions 7 and 16, specifically C and E, respectively, take part in an intrachain covalent linkage referred to as 4-cysteinyl-glutamic acid (Cys-Glu).
The residues at positions 27 and 33, specifically C and D, respectively, take part in an intrachain covalent linkage referred to as 3-cysteinyl-aspartic acid (Cys-Asp).
The residues at positions 37 and 43, specifically C and W, respectively, take part in an intrachain covalent linkage referred to as 4'-cysteinyl-tryptophylquinone (Cys-Trp).
The residues at positions 41 and 49, specifically C and D, respectively, take part in an intrachain covalent linkage referred to as 3-cysteinyl-aspartic acid (Cys-Asp).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 698.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 939.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 967.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1000.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1005.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1343.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1356.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1370.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1448.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1464.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1523.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1523.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1534.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1560.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1630.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2442.
The residues at positions 59 and 61, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 555.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 299.
The residues at positions 82 and 84, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form BTD-3, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit B); in form BTD-1, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit C); in form BTD-4, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit D); in form BTD-7, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form BTD-3, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit B); in form BTD-1, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit C); in form BTD-4, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit D); in form BTD-7, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 402.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 393.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 285.
The residues at positions 67 and 70, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 72 and 76, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1049.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1049.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1085.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1819.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 189.
The residues at positions 646 and 682, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 217.
The residues at positions 30 and 60, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 363.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 697.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 697.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 736.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 383.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); by autocatalysis, involves the residue K present at position 903.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 222.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 14.
The residues at positions 43 and 71, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 176 and 293, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 541 and 618, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 631 and 715, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 728 and 805, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 818 and 902, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 915 and 992, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The residues at positions 1005 and 1089, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1020.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1024.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 340.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 340.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 428.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 99.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 245.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 714.
The residues at positions 26 and 55, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 484.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 478.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 478.
The residues at positions 79 and 138, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 634.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1008.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1008.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1131.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 767.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 893.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1013.
The residues at positions 140 and 273, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-299).
The residues at positions 273 and 299, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-140).
The residues at positions 65 and 67, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ser-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 585.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 680.
The residues at positions 100 and 247, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-273).
The residues at positions 247 and 273, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-100).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1413.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1167.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1587.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1601.
The residues at positions 211 and 213, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 11 and 16, specifically W and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Trp-Pro).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 65.
The residues at positions 44 and 73, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 248.
The residues at positions 220 and 223, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The residues at positions 102 and 224, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-250).
The residues at positions 224 and 250, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-102).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 248.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 287.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 300.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 306.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 310.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 320.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 332.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 336.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 374.
The residues at positions 652 and 688, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 452.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 815.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 705.
The residues at positions 1 and 37, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 633.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2451.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1495.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1495.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1872.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1922.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1922.
The residues at positions 190 and 192, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 577.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 651.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 712.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 794.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 807.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1024.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 555.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-322 in alpha-fibrinogen), involves the residue Q present at position 41.
The residues at positions 29 and 58, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 442.
The residues at positions 1006 and 1009, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 56.
The residues at positions 1008 and 1011, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1252.
The residues at positions 108 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-255).
The residues at positions 229 and 255, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-108).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1021.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 418.
The residues at positions 620 and 656, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 841.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 294.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1804.
The residues at positions 182 and 199, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The residues at positions 171 and 188, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 518.
The residues at positions 477 and 512, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr); alternate.
The residues at positions 92 and 217, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-243).
The residues at positions 217 and 243, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1220.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1499.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1571.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1591.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1698.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1780.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1946.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2104.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2444.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2504.
The residues at positions 36 and 168, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The establishment of interchain covalent linkage, termed Threonyl lysine isopeptide (Lys-Thr) (interchain with T-311), involves the residue K present at position 161.
The residues at positions 179 and 303, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The establishment of interchain covalent linkage, termed Threonyl lysine isopeptide (Thr-Lys) (interchain with K-161); alternate, involves the residue T present at position 311.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 853.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 633.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 546.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 559.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 573.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 603.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 623.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 635.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 639.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 645.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 661.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 677.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-263 in ATG5), involves the residue G present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 162.
The residues at positions 73 and 76, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 206.
The residues at positions 50 and 56, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 58 and 61, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 62 and 65, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 929.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 929.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1098.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1173.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1210.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1231.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1428.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1510.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1524.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1613.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 540.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 546.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 554.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 830.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 863.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1031.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 388.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 846.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 848.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1142.
The residues at positions 45 and 75, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 251.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 329.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 349.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 361.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 365.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 371.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 403.
The residues at positions 95 and 97, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1642.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1654.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1656.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 697.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 751.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 233.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1744.
The residues at positions 107 and 235, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-261).
The residues at positions 235 and 261, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-107).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 792.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 963.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 73.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 45.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 536.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 768.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 834.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 232.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 41.
The residues at positions 108 and 247, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-273).
The residues at positions 247 and 273, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-108).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 160.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1P1/SUMO5); alternate, involves the residue K present at position 160.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in /SUMO5); alternate, involves the residue K present at position 380.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 380.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 380.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1P1/SUMO5); alternate, involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 476.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1P1/SUMO5); alternate, involves the residue K present at position 490.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1P1/SUMO5); alternate, involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 946.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1218.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1317.
The residues at positions 638 and 674, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 498.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 502.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 502.
The residues at positions 30 and 31, specifically C and S, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Cys-Ser).
The residues at positions 38 and 48, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 49 and 54, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 51 and 58, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 954.
The residues at positions 60 and 62, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 835.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1147.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1257.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form RTD-1, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit B); in form RTD-2, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form RTD-1, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit B); in form RTD-2, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 115.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 597.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 597.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 64.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 64.
The residues at positions 100 and 221, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-247).
The residues at positions 221 and 247, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-100).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 105.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1125.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1395.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in histone H2A, involves the residue K present at position 14.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in histone H2A, involves the residue K present at position 16.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 701.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 982.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1219.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1319.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 191.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 364.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 945.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1161.
The residues at positions 102 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-256).
The residues at positions 229 and 256, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-102).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 477.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 532.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 805.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 368.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 358.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 855.
The residues at positions 510 and 545, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 1576.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit A); in form RTD-3, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Arg-Cys) (interchain with C-73 in subunit B); in form RTD-1, involves the residue R present at position 65.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit A); in form RTD-3, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Cyclopeptide (Cys-Arg) (interchain with R-65 in subunit B); in form RTD-1, involves the residue C present at position 73.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 28.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 89.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 325.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in UFM1), involves the residue K present at position 367.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 49.
The residues at positions 117 and 179, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 245.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 11.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 536.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 124.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 138.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 443.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 443.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 938.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 367.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 485.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 810.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1002.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1569.
The residues at positions 41 and 47, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 53 and 56, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 347.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 774.
The residues at positions 23 and 86, specifically L and W, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 202.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 998.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1033.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1056.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1942.
The residues at positions 147 and 149, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ser-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 402.
The residues at positions 115 and 179, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 985 and 988, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 69.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 159.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 622.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 232.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 232.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 117.
The establishment of interchain covalent linkage, termed Glycyl serine ester (Ser-Gly) (interchain with G-Cter in ubiquitin), involves the residue S present at position 2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 521.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 655.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 655.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1082.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1249.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 27.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1032.
The residues at positions 72 and 102, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 217.
The residues at positions 61 and 64, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 408.
The residues at positions 96 and 229, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-255).
The residues at positions 229 and 255, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 959.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 979.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 580.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 580.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 831.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 831.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 911.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 66.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 98.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 98.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 67.
The residues at positions 254 and 258, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in TtuB), involves the residue C present at position 192.
The residues at positions 9 and 13, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 266.
The residues at positions 115 and 238, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-264).
The residues at positions 238 and 264, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-115).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 87.
The residues at positions 23 and 36, specifically Y and Y, respectively, take part in an intrachain covalent linkage referred to as Isodityrosine (Tyr-Tyr); alternate.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 100.
The residues at positions 9 and 43, specifically N and G, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Asn-Gly).
The residues at positions 12 and 39, specifically C and F, respectively, take part in an intrachain covalent linkage referred to as 2-cysteinyl-D-phenylalanine (Cys-Phe).
The residues at positions 15 and 36, specifically C and T, respectively, take part in an intrachain covalent linkage referred to as 2-cysteinyl-D-allo-threonine (Cys-Thr).
The residues at positions 21 and 30, specifically C and F, respectively, take part in an intrachain covalent linkage referred to as 2-cysteinyl-L-phenylalanine (Cys-Phe).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 381.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 500.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 827.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 185.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 160.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 676.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 676.
The residues at positions 114 and 165, specifically W and W, respectively, take part in an intrachain covalent linkage referred to as Tryptophan tryptophylquinone (Trp-Trp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 880.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1182.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1216.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1234.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1292.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1414.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 395.
The residues at positions 25 and 58, specifically K and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl lysine isopeptide (Lys-Gln); in form cyclo-statherin Q-39.
The residues at positions 25 and 56, specifically K and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl lysine isopeptide (Lys-Gln); in form cyclo-statherin Q-37.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 460.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 460.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 725.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 755.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 755.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1224.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1248.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1414.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 736.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3), involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 266.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 783.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 541.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 611.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 789.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); in isoform 2, involves the residue K present at position 121.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 994.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1188.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1397.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1561.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 706.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 706.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 993.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 531.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 344.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 259.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 910.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 915.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1539.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1547.
The residues at positions 63 and 65, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The residues at positions 67 and 69, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1039.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1177.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1225.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 1607.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 554.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 120.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in lgg-3/ATG12), involves the residue K present at position 129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 331.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 479.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1307.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 744.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 319.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 668.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 596.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 766.
The residues at positions 39 and 48, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as Pyridine-2,5-dicarboxylic acid (Ser-Ser) (with C-47).
The residues at positions 39 and 47, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Pyridine-2,5-dicarboxylic acid (Ser-Cys) (with S-48).
The residues at positions 39 and 40, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The residues at positions 42 and 43, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Thr-Cys).
The residues at positions 44 and 45, specifically V and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Val-Cys).
The residues at positions 46 and 47, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Thr-Cys).
The residues at positions 48 and 49, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The residues at positions 49 and 50, specifically C and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Cys-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 946.
The residues at positions 92 and 154, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1169.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1172.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in acceptor proteins), involves the residue Q present at position 59.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 668.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 18.
The residues at positions 119 and 181, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1353.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1747.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 67.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 67.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 842.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 724.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 724.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 724.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 742.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 742.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 950.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1681.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1748.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin and interchain with MARCHF2), involves the residue K present at position 326.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 464.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 624.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP1); alternate, involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP3); alternate, involves the residue K present at position 240.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP1); alternate, involves the residue K present at position 247.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP3); alternate, involves the residue K present at position 247.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 268.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 861.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1047.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 289.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 423.
The residues at positions 54 and 139, specifically Y and C, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Tyr-Cys).
The residues at positions 52 and 137, specifically Y and C, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Tyr-Cys).
The residues at positions 149 and 151, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1.
The residues at positions 116 and 178, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 702.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1392.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1504.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1737.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1864.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 517.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 517.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-172 in ATG5), involves the residue G present at position 179.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 213.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 213.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 276.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 336.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 336.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 383.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1339.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2616.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 254.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 135.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 119.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 272.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 509.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-150 in ATG5), involves the residue G present at position 210.
The residues at positions 56 and 67, specifically I and T, respectively, take part in an intrachain covalent linkage referred to as 4-(1-hydroxyethyl)-7-isoleucino-2-(threonin-O3-ylcarbonyl)-7,8-dihydroquinolin-8-ol (Ile-Thr).
The residues at positions 60 and 69, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as 5-amino-piperideine-2,5-dicarboxylic acid (Ser-Ser) (with C-68).
The residues at positions 60 and 68, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as 5-amino-piperideine-2,5-dicarboxylic acid (Ser-Cys) (with S-69).
The residues at positions 60 and 61, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The residues at positions 63 and 64, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as (4S)-thiazoline-4-carboxylic acid (Thr-Cys).
The residues at positions 65 and 66, specifically I and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ile-Cys).
The residues at positions 67 and 68, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Thr-Cys).
The residues at positions 69 and 70, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 680.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 401.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 525.
The residues at positions 112 and 235, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-261).
The residues at positions 235 and 261, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-112).
The residues at positions 98 and 221, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-248).
The residues at positions 221 and 248, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-98).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 516.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 565.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 635.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 814.
The residues at positions 92 and 215, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-241).
The residues at positions 215 and 241, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 446.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-125 in ATG5), involves the residue G present at position 213.
The residues at positions 113 and 180, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 102 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-102).
The residues at positions 993 and 996, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 1 and 28, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The residues at positions 27 and 34, specifically G and E, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl glycine isopeptide (Gly-Glu).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1424.
The residues at positions 93 and 95, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 328.
The residues at positions 48 and 56, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 594.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 673.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1037.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 345.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 375.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 900.
The residues at positions 224 and 226, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 695.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1350.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 445.
The residues at positions 639 and 675, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 113.
The establishment of interchain covalent linkage, termed 1-(tryptophan-3-yl)-tryptophan (Trp-Trp) (interchain with W-33), involves the residue W present at position 33.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 225.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 225.
The residues at positions 93 and 236, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-262).
The residues at positions 236 and 262, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-93).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1344.
The residues at positions 278 and 282, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 338.
The residues at positions 85 and 208, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-234).
The residues at positions 208 and 234, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-85).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 245.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 478.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 579.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 590.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 596.
The residues at positions 320 and 355, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 476.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 545.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 551.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 246.
The residues at positions 134 and 196, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 67 and 96, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asn).
The residues at positions 122 and 151, specifically G and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Gly-Asp).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 528.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 941.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1041.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1048.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 389.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 561.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 561.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15), involves the residue K present at position 142.
The residues at positions 13 and 20, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 18 and 23, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 21 and 24, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as S-(2-aminovinyl)-D-cysteine (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 437.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1073.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1140.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1269.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 94.
The residues at positions 96 and 223, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-249).
The residues at positions 223 and 249, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-96).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 86.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 435.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 830.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 830.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 365.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1208.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 513.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 838.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 840.
The residues at positions 251 and 255, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 280.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 795.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1195.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1400.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1423.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1525.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 101.
The residues at positions 52 and 56, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 58 and 61, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 428.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 82.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 608.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 868.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 456.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 682.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 228.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-5 in histone H4), involves the residue Q present at position 10.
The residues at positions 111 and 174, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1051.
The residues at positions 36 and 41, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 38 and 52, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 45 and 53, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 62 and 211, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 243 and 546, specifically K and D, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asp).
The residues at positions 374 and 526, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 562 and 667, specifically K and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl lysine isopeptide (Lys-Asn).
The establishment of interchain covalent linkage, termed Threonyl lysine isopeptide (Thr-Lys) (interchain with K-? in major pilin subunit), involves the residue T present at position 675.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 718.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 595.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1432.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 978.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1580.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1769.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1935.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2093.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2282.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2493.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 932.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 315.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in ATG5), involves the residue G present at position 95.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 256.
The residues at positions 1187 and 1190, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2136.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 418.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3); alternate, involves the residue K present at position 586.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 588.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-148 in ATG5), involves the residue G present at position 132.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 50.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 144.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 363.
The residues at positions 11 and 18, specifically C and P, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Cys-Pro).
The residues at positions 66 and 68, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 35.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1807.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1808.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2024.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 524.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1313.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 432.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 403.
The residues at positions 92 and 240, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-266).
The residues at positions 240 and 266, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 103.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 117.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 153.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 156.
The residues at positions 125 and 272, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-298).
The residues at positions 272 and 298, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-125).
The residues at positions 1 and 8, specifically G and N, respectively, take part in an intrachain covalent linkage referred to as Isoaspartyl glycine isopeptide (Gly-Asn).
The residues at positions 43 and 53, specifically S and S, respectively, take part in an intrachain covalent linkage referred to as Pyridine-2,5-dicarboxylic acid (Ser-Ser) (with C-52).
The residues at positions 43 and 52, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Pyridine-2,5-dicarboxylic acid (Ser-Cys) (with S-53).
The residues at positions 43 and 44, specifically S and T, respectively, take part in an intrachain covalent linkage referred to as 5-methyloxazole-4-carboxylic acid (Ser-Thr).
The residues at positions 45 and 46, specifically N and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Asn-Cys).
The residues at positions 47 and 48, specifically F and C, respectively, take part in an intrachain covalent linkage referred to as Thiazoline-4-carboxylic acid (Phe-Cys).
The residues at positions 50 and 51, specifically I and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ile-Cys).
The residues at positions 51 and 52, specifically C and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Cys-Cys).
The residues at positions 53 and 54, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Ser-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-153 in atg5), involves the residue G present at position 172.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 605.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1039.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1369.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1381.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 79.
The residues at positions 283 and 287, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 7.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 530.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 517.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 182.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 67.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in Factor 3(A)), involves the residue Q present at position 77.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-? in Factor 3(A)), involves the residue Q present at position 78.
The residues at positions 1009 and 1012, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue C present at position 281.
The residues at positions 95 and 155, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 429.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 694.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 971.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 971.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 64.
The residues at positions 124 and 245, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-271).
The residues at positions 245 and 271, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-124).
The residues at positions 989 and 992, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 338.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 599.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 629.
The residues at positions 323 and 358, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 250.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 255.
The residues at positions 129 and 251, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-277).
The residues at positions 251 and 277, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-129).
The residues at positions 92 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-92).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 1204.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 256.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 429.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 346.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1088.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1094.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1192.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1723.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 143.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 162.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 166.
The residues at positions 147 and 151, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 178.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2027.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-144 in ATG5), involves the residue G present at position 247.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?), involves the residue Q present at position 632.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1087.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 221.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 243.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 260.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 283.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 293.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 315.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 331.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-149 in ATG5), involves the residue G present at position 189.
The residues at positions 82 and 173, specifically V and Y, respectively, take part in an intrachain covalent linkage referred to as 3-(O4'-tyrosyl)-valine (Val-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 217.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 335.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 372.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 464.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 464.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 60.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 267.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1667.
The residues at positions 207 and 209, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 121.
The establishment of interchain covalent linkage, termed Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin), involves the residue C present at position 12.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 542.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2 and SUMO3), involves the residue K present at position 226.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 301.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 328.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 381.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 592.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 592.
The residues at positions 112 and 175, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 354.
The residues at positions 266 and 270, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 650.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 650.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 651.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 651.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 740.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 740.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 794.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 36.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 277.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 456.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 456.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 799.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1275.
The residues at positions 113 and 177, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 561.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 374.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1419.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1511.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1546.
The residues at positions 93 and 158, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 426.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1012.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 378.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 822.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 824.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Glu-Lys) (interchain with K-? in acceptor proteins), involves the residue E present at position 62.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1375.
The residues at positions 86 and 208, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-234).
The residues at positions 208 and 234, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-86).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 980.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1021.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 916.
The residues at positions 975 and 978, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 940.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 394.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 598.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 996.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 508.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 833.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 835.
The residues at positions 1080 and 1083, specifically C and Q, respectively, take part in an intrachain covalent linkage referred to as Isoglutamyl cysteine thioester (Cys-Gln).
The residues at positions 80 and 82, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 560.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SAMP2), involves the residue K present at position 58.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins); alternate, involves the residue G present at position 66.
The residues at positions 113 and 175, specifically H and C, respectively, take part in an intrachain covalent linkage referred to as 6-(S-cysteinyl)-8alpha-(pros-histidyl)-FAD (His-Cys).
The residues at positions 39 and 108, specifically L and W, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Leu-Trp).
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 474.
The residues at positions 294 and 298, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 176.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 583.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 457.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 480.
The residues at positions 1 and 29, specifically H and D, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (His-Asp).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 8.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 524.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 12.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 150.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1107.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 207.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 209.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 210.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 382.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 562.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 567.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 573.
The establishment of interchain covalent linkage, termed (Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 587.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 4.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 30.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 1004.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 51.
The residues at positions 233 and 237, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The residues at positions 194 and 211, specifically C and H, respectively, take part in an intrachain covalent linkage referred to as 2'-(S-cysteinyl)-histidine (Cys-His).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1266.
The residues at positions 35 and 39, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys); by FlvM2.
The residues at positions 54 and 60, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The residues at positions 66 and 69, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys); by FlvM2.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 320.
The residues at positions 183 and 185, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 797.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 439.
The residues at positions 152 and 154, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 701.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 701.
The residues at positions 63 and 65, specifically E and G, respectively, take part in an intrachain covalent linkage referred to as 2-iminomethyl-5-imidazolinone (Glu-Gly).
The residues at positions 105 and 107, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 526.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 526.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1153.
The residues at positions 107 and 177, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3'-(S-cysteinyl)-tyrosine (Cys-Tyr).
The residues at positions 205 and 207, specifically A and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ala-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 601.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 412.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ATG12), involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 241.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 691.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate, involves the residue K present at position 129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 129.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 2055.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2092.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2149.
The residues at positions 273 and 277, specifically H and Y, respectively, take part in an intrachain covalent linkage referred to as 1'-histidyl-3'-tyrosine (His-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1299.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 546.
The residues at positions 39 and 40, specifically G and C, respectively, take part in an intrachain covalent linkage referred to as Thiazole-4-carboxylic acid (Gly-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 17.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in atg12), involves the residue K present at position 97.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 847.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 847.
The residues at positions 47 and 51, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 59 and 63, specifically S and C, respectively, take part in an intrachain covalent linkage referred to as Lanthionine (Ser-Cys).
The residues at positions 65 and 68, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The residues at positions 69 and 72, specifically T and C, respectively, take part in an intrachain covalent linkage referred to as Beta-methyllanthionine (Thr-Cys).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1374.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1496.
The residues at positions 224 and 226, specifically S and G, respectively, take part in an intrachain covalent linkage referred to as 5-imidazolinone (Ser-Gly).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 19.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate, involves the residue K present at position 265.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 316.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 374.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 838.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 838.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 896.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 670.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 888.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1011.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 133.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 291.
The residues at positions 356 and 379, specifically C and Y, respectively, take part in an intrachain covalent linkage referred to as 3-(S-cysteinyl)-tyrosine (Cys-Tyr).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1145.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1171.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1273.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1376.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1481.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1497.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate, involves the residue K present at position 1556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 1556.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1567.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 1593.
The residues at positions 215 and 216, specifically C and S, respectively, take part in an intrachain covalent linkage referred to as N,N-(cysteine-1,S-diyl)serine (Cys-Ser); in inhibited form.
The residues at positions 1 and 28, specifically D and N, respectively, take part in an intrachain covalent linkage referred to as Cyclopeptide (Asp-Asn).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 158.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 272.
The residues at positions 103 and 225, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-251).
The residues at positions 225 and 251, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-103).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 679.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in NEDD8), involves the residue K present at position 709.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 927.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate, involves the residue K present at position 2073.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2110.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 2167.
The residues at positions 2 and 31, specifically Y and K, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Tyr-Lys).
The residues at positions 17 and 65, specifically C and C, respectively, take part in an intrachain covalent linkage referred to as S-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys); in chain B.
The residues at positions 30 and 108, specifically K and Y, respectively, take part in an intrachain covalent linkage referred to as Lysine tyrosylquinone (Lys-Tyr).
The establishment of interchain covalent linkage, termed 5'-tyrosyl-5'-aminotyrosine (Tyr-Tyr) (interchain with Y-108), involves the residue Y present at position 108.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 907.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2), involves the residue K present at position 931.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 364.
The establishment of interchain covalent linkage, termed Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-Cter in protein Pup), involves the residue K present at position 157.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 1247.
The residues at positions 111 and 234, specifically W and Y, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Trp-Tyr) (with M-260).
The residues at positions 234 and 260, specifically Y and M, respectively, take part in an intrachain covalent linkage referred to as Tryptophyl-tyrosyl-methioninium (Tyr-Met) (with W-111).
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), involves the residue K present at position 744.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins), involves the residue G present at position 111.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1), involves the residue K present at position 237.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 258.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 286.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 618.
The establishment of interchain covalent linkage, termed Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), involves the residue K present at position 630.